Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study.

Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study.

Standard treatment for osteosarcoma patients consists of a combination of cisplatin, adriamycin, and methotrexate before surgical resection of the primary tumour, followed by postoperative chemotherapy including vincristine and cyclophosphamide. Unfortunately, many patients still relapse or suffer a...

Full description

Bibliographic Details
Main Authors: Daniela Caronia, Ana Patiño-Garcia, Antonio Peréz-Martínez, Guillermo Pita, Leticia Tais Moreno, Marta Zalacain-Díez, Blanca Molina, Isabel Colmenero, Luis Sierrasesúmaga, Javier Benítez, Anna Gonzalez-Neira
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3189235?pdf=render

Internet

http://europepmc.org/articles/PMC3189235?pdf=render

Similar Items